Biomarkers | Diagnosis | Europe | International | New Techniques | Prognosis | Updates
New Clinical Trial Aims to Create Bioresource for Improved Mesothelioma Diagnosis
Malignant mesothelioma is not only one of the rarest and most difficult-to-treat cancers. It is also among the hardest to…